IMPROvE-CED Trial: Intracoronary Autologous CD34+ Cell Therapy for Treatment of Coronary Endothelial Dysfunction in Patients With Angina and Nonobstructive Coronary Arteries.
Michel T CorbanTakumi ToyaDiana AlbersFaten SebaaliBradley R LewisJohn BoisRajiv GulatiAbhiram PrasadPatricia J M BestMalcolm R BellCharanjit S RihalMegha PrasadAli AhmadLilach Orly LermanMary L SolsethJeffrey Lawrence WintersAllan B DietzAmir LermanPublished in: Circulation research (2021)
A single intracoronary autologous CD34+ cell infusion was safe and may potentially be an effective disease-modifying therapy for microvascular CED in humans. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03471611.
Keyphrases